Concepedia

Song Wu

SW

Statistics

Publications

1

Citations

29

H-Index

1

Active since

2023

Affiliations

AstraZeneca (Japan)(Current)

Song Wu is an author at AstraZeneca (Japan).

ORCID

Publications per year

2023–2023

1

Publications

1

Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Sophie Wildsmith, Weimin Li, Song Wu et al. · Clinical Cancer Research · 2023 · 29 citations · Full text

1–1 of 1